happy to let me work on my own project. This year of training was not only practical but exposed me to the mouse genetics community. Together with Davor, I published what I think was the first paper to study retrovirus biology using transgenic mice.
This began my journey of studying host-virus interactions using genetics. This journey has taken me from studies on the regulation of MMTV transcription to using mice to understand the genetics of susceptibility to infection to various viruses. For example, using transgenic mice, we showed that mice retain copies of endogenous MMTV in their genome as protection from exogenous infection. We also figured out why MMTV encoded a viral superantigen. Superantigens are presented by major histocompatibility class II proteins to CD4 T helper cells by interacting only with the T cell receptor (TCR) β chain, which causes massive stimulation of T cells. Tatyana Golovkina, then a postdoc in my lab, showed that transgenic mice expressing viral superantigens as endogenous genes were protected against infection. This is because superantigen-specific T cells are deleted during neonatal shaping of the immune repertoire, resulting in the loss of a reservoir of actively dividing, infection-competent cells. These studies showed the power of using genetically manipulated mice to study virus biology. However, while we know that there are endogenous retroviruses in all species, many of which play important roles in the biology of their hosts, it has not yet been demonstrated that these viruses directly protect against exogenous infection in humans, an area yet to be explored.
Since that time, we have gone on to identify many other genes that determine susceptibility to infection, including those involved in immune responses and virus entry. The identification of entry receptors has also helped us understand species-specific virus tropism, including why MMTV likely doesn't infect humans. Through these studies, we have expanded our virus portfolio to include both human and mouse retroviruses as well as New World hemorrhagic fever arenaviruses, and we have gone into research areas I never thought I would be involved in, including drug discovery and recently even neurology. While my lab now uses a variety of approaches to identify the genes that confer resistance and susceptibility, we always end up in the mouse. The mouse has sometimes led us from our best-laid plans, but more often than not, it has led us to new, exciting avenues of exploration.
